BPG is committed to discovery and dissemination of knowledge
Articles in Press
2/25/2025 7:53:23 AM | Browse: 34 | Download: 0
Publication Name World Journal of Critical Care Medicine
Manuscript ID 101327
Country United States
Category Critical Care Medicine
Manuscript Type Retrospective Study
Article Title Impact of proning with and without inhaled pulmonary vasodilators and neuromuscular blocking agents in COVID acute respiratory distress syndrome
Manuscript Source Unsolicited Manuscript
All Author List Matthew Cabrera, Sarika Bharil, Meghan Chin, Seife Yohannes and Paul Clark
Funding Agency and Grant Number
Corresponding Author Matthew Cabrera, MD, Department of Critical Care Medicine, Georgetown University School of Medicine, 3900 Reservoir Road NW, Washington, DC 20007, United States. mpc125@georgetown.edu
Key Words Acute respiratory distress syndrome; COVID; Prone position ventilation; Neuromuscular blocking agents; Pulmonary vasodilators; Mechanical ventilation; Plateau pressure; Driving pressure; Peak end expiratory pressure
Core Tip In this retrospective study at two tertiary academic medical centers during the initial coronavirus disease 2019 surge, we examine trends in ventilator mechanics and outcomes of 114 acute respiratory distress syndrome (ARDS) patients receiving three adjunct therapies (prone positioning, neuromuscular blockade and inhaled vasodilations). We found a significant improvement in arterial oxygen partial pressure/fractional inspired oxygen ratio with the addition of inhaled vasodilators while proning and in lung compliance with the addition of continuous neuromuscular blockade amoung others. Our groups were not large enough to detect a difference in mortality or length of stay. However, this study provides a large amount of data and multi-day trends to further our understanding of the physiologic response to multiple adjunct therapies for ARDS in combination.
Citation Cabrera M, Bharil S, Chin M, Yohannes S, Clark P. Impact of proning with and without inhaled pulmonary vasodilators and neuromuscular blocking agents in COVID acute respiratory distress syndrome. World J Crit Care Med 2025; In press
Received
2024-09-10 23:53
Peer-Review Started
2024-09-10 23:53
To Make the First Decision
Return for Revision
2025-01-20 06:22
Revised
2025-02-03 05:55
Second Decision
2025-02-25 02:50
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-02-25 07:53
Articles in Press
2025-02-25 07:53
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2025-05-15 06:54
ISSN 2220-3141(online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com